| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2019 | CRL Charles River Laboratories International, Inc. | Girshick Birgit65 | Corporate Executive VP | Sell | 2,874 | $144.93 | $416,516.02 | -0.5% | |
| Dec 9, 2019 | CRL Charles River Laboratories International, Inc. | Girshick Birgit65 | Corporate Executive VP | Sell | 2,420 | $144.21 | $348,993.29 | -0.4% | |
| Dec 6, 2019 | VCYT Veracyte, Inc. | Hanna John Walter Jr | Chief Commercial Officer | Sell | 17,938 | $30.05 | $539,041.90 | -12.1% | |
| Dec 6, 2019 | VCYT Veracyte, Inc. | Kennedy Keith | COO / CFO | Sell | 33,151 | $30.02 | $995,215.85 | -13.1% | |
| Dec 6, 2019 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 5,951 | $30.00 | $178,557.63 | -1.7% | |
| Dec 5, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,000 | $1.60 | $80,000.00 | - | |
| Dec 5, 2019 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 32,803 | $29.39 | $964,142.50 | -41.2% | |
| Dec 4, 2019 | RVTY Revvity, Inc. | Okun Andrew76 | Please See Remarks | Sell | 11,984 | $90.87 | $1,088,986.08 | -44.1% | |
| Dec 4, 2019 | BIO Bio-Rad Laboratories, Inc. | Ernst Timothy S69 | EVP, General Counsel &Sec | Sell | 1,906 | $370.11 | $705,436.22 | -54.9% | |
| Dec 4, 2019 | MTD Mettler Toledo International Inc/ | Kirk Simon | Head Of Product Inspection | Sell | 2,523 | $733.02 | $1,849,421.32 | -37.0% | |
| Dec 3, 2019 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 2,690 | $72.78 | $195,778.20 | -67.4% | |
| Dec 3, 2019 | CDNA Caredx, Inc. | Hagstrom William A61 | Director | Sell | 12,500 | $20.06 | $250,761.25 | -44.8% | |
| Dec 3, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,286 | $1.60 | $16,457.60 | - | |
| Dec 3, 2019 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 15,327 | $26.47 | $405,662.77 | -24.6% | |
| Dec 2, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,000 | $1.56 | $77,755.22 | - | |
| Dec 2, 2019 | PRPO Precipio, Inc. | Danieli Ilan | Chief Executive Officer | Buy | 1,176 | $2.09 | $2,463.13 | +9.1% | |
| Dec 2, 2019 | PRPO Precipio, Inc. | Sabet Ahmed Zaki47 | Chief Operations Officer | Buy | 127 | $2.11 | $267.55 | -103.2% | |
| Nov 29, 2019 | MTD Mettler Toledo International Inc/ | De La Guerroniere Marc56 | Head Of Eur &Na Market Orgs. | Sell | 4,000 | $724.60 | $2,898,404.13 | -2.9% | |
| Nov 27, 2019 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 3,697 | $29.36 | $108,534.31 | -7.2% | |
| Nov 26, 2019 | WAT Waters Corp /de/ | Conard Edward | Director | Sell | 1,112 | $221.97 | $246,830.64 | -1.6% | |
| Nov 26, 2019 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 4,206 | $80.19 | $337,279.14 | -0.1% | |
| Nov 26, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.55 | $154,500.33 | - | |
| Nov 26, 2019 | VCYT Veracyte, Inc. | Hanna John Walter Jr | Chief Commercial Officer | Sell | 17,938 | $28.55 | $512,089.15 | -12.0% | |
| Nov 25, 2019 | VCYT Veracyte, Inc. | Kennedy Keith | COO / CFO | Sell | 18,757 | $28.01 | $525,475.48 | -14.6% | |
| Nov 25, 2019 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 538 | $78.17 | $42,055.46 | -29.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.